阿维菌素自诞生以来,就备受生产企业关注,不断更新生产工艺,开发新剂型,其原药和制剂产能正在以惊人的速度增长,我国也已成为全球最大的阿维菌素供应国。但由于产能已经过剩,我国阿维菌素企业正面临新一轮挑战。近年来,中国阿维菌素企业面临一些问题:生产环节废水、废气排放较多, Since its inception, avermectin has attracted the attention of production companies, constantly updating its production processes and developing new dosage forms. The production capacity of its original drugs and preparations is growing at an alarming rate. China has also become the world’s largest avermectin supplier. . However, due to excess production capacity, China’s abamectin companies are facing a new round of challenges. In recent years, avermectin companies in China are facing some problems: more waste water and exhaust gas from the production process,